Address	880 Third Avenue New York New York 10022 United States
Employees	-
Website	http://www.relmada.com
Updated	07/08/2019
Relmada Therapeutics, Inc. is a clinical-stage and biotechnology company, which engages in developing drug products together with new chemical entities that address areas of unmet medical need in the treatment of central nervous system diseases. Its portfolio of products include d-Methadone, LevoCap ER, BuTab REL-1028, and MepiGel REL-1021. The company was founded on May 31, 2012 and is headquartered in New York, NY.